Surgalign Competitors

Delisted . USA . 
Stock . Surgalign Holdings
SRGADelisted Stock  USD 0.04  0  12.54%   
Surgalign Holdings competes with Paragon 28, Orthofix Medical, Si Bone, Avanos Medical, and Establishment Labs; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Surgalign Holdings competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Surgalign Holdings to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Surgalign Holdings competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.030.040.04
Details
Intrinsic
Valuation
LowRealHigh
0.030.030.04
Details
Naive
Forecast
LowNextHigh
0.300.300.30
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.050.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Surgalign Holdings. Your research has to be compared to or analyzed against Surgalign Holdings' peers to derive any actionable benefits. When done correctly, Surgalign Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Surgalign Holdings.

Surgalign Holdings Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Surgalign Holdings and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Surgalign and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Surgalign Holdings does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CVRX
+ 0.9
OFIX
OFIX
+ 0.83
FNA
TLIS
+ 0.79
AVNS
CVRX
+ 0.66
FNA
CVRX
+ 0.58
AZYO
FNA
+ 0.46
NUVA
  
High negative correlations   
TLIS
- 0.9
FNA
CVRX
- 0.86
AVNS
AVNS
- 0.78
OFIX
AVNS
- 0.72
FNA
TLIS
- 0.69
OFIX
TLIS
- 0.61
CVRX

Risk-Adjusted Indicators

There is a big difference between Surgalign Stock performing well and Surgalign Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Surgalign Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NUVA  1.23  0.02  0.00  0.05  0.00 
 0.00 
 3.31 
(2.75)
 7.19 
FNA  3.61  0.47  0.16  0.29  3.34 
(4.15)
 7.32 
(5.83)
 43.16 
OFIX  1.66 (0.02) 0.00  0.07  1.85 
(1.87)
 3.87 
(3.15)
 12.11 
SIBN  2.77 (0.30) 0.00 (0.08) 0.00 
 0.00 
 5.99 
(4.54)
 26.24 
AVNS  1.72 (0.54) 0.00 (0.21) 0.00 
 0.00 
 3.01 
(2.91)
 20.91 
AZYO  3.96  0.63  0.13  2.41  3.84 
(5.00)
 8.44 
(7.23)
 30.62 
ESTA  3.27  0.07  0.03  0.14  3.81 
(3.48)
 8.20 
(6.43)
 22.26 
CVRX  3.75  0.89  0.20  1.48  3.38 
(4.43)
 10.68 
(8.91)
 41.08 
AXGN  2.36  0.00  0.01  0.09  3.77 
(2.35)
 4.75 
(5.50)
 21.60 
TLIS  4.85 (1.98) 0.00 (1.99) 0.00 
 0.00 
 5.32 
(10.69)
 68.77 
All Fundamental Data

Surgalign Holdings Competitive Analysis

The better you understand Surgalign Holdings competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Surgalign Holdings' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Surgalign Holdings' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SRGA NUVA FNA OFIX SIBN AVNS AZYO ESTA CVRX AXGN
 12.54 
 0.04 
Surgalign
 1.97 
 42.35 
NuVasive
 1.86 
 10.42 
Paragon
 0.72 
 17.96 
Orthofix
 1.40 
 13.42 
SIBN
 2.55 
 17.97 
Avanos
 0.00 
 2.44 
Aziyo
 0.63 
 46.00 
Establishment
 4.25 
 12.83 
CVRx
 1.73 
 14.16 
Axogen
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Slightly risky
Very steady
Not too volatile
Not too volatile
Very steady
Very steady
Somewhat reliable
Somewhat reliable
Market Performance
(90 Days Performance)
Very Weak
Very Weak
OK
Modest
Very Weak
Very Weak
Very Weak
Weak
Good
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
Below Average
Low
Low
Below Average
Dangerous
Below Average
Below Average
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Buy
Strong Buy
Buy
Not Available
Strong Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Sell
Cautious Hold
Cautious Hold
Strong Hold
Not Rated
Strong Sell
Cautious Hold
Strong Sell
Current Ratio
2.33
1.17
3.66
3.15
8.9
2.89
1.0
4.27
16.82
4.52
Net Asset
70.24 M
2.22 B
340.7 M
925.32 M
230.43 M
1.69 B
68.84 M
268.64 M
115.23 M
196.83 M
Profit Margin
-0.65
0.0232
-0.23
-0.15
-0.24
0.023
-0.7
-0.46
-1.24
-0.0791
EBITDA
(68.28 M)
211.8 M
(21.77 M)
(79.45 M)
(34.45 M)
50.6 M
(22.38 M)
(58.31 M)
(43.1 M)
(13.33 M)
Operating Margin
-0.68
0.0673
-0.14
-0.0861
-0.19
0.0968
-0.5
-0.33
-0.97
-0.0065
Current Valuation
(7.93 M)
2.91 B
943.84 M
793.51 M
450.53 M
939.05 M
40.69 M
1.48 B
261.58 M
667.49 M
Price To Book
1.79
2.62
6.26
1.31
3.41
0.67
13.34
40.45
4.78
6.27
Retained Earnings
(624.22 M)
86.11 M
(115.63 M)
(150.14 M)
(400.44 M)
(314.9 M)
(137.99 M)
(360.1 M)
(477.38 M)
(281.3 M)
Current Asset
N/A
702.83 M
N/A
147.87 M
266 K
773.54 M
N/A
60.91 M
N/A
35.05 M
Beta
1.8
1.07
1.01
1.05
1.23
0.93
-0.18
1.21
1.11
1.13
Number Of Employees
217
3 K
574
1.63 K
344
3.77 K
151
908
200
426
Shares Outstanding
9.18 M
52.45 M
83.72 M
38.21 M
41.94 M
45.96 M
11.92 M
28.76 M
24.26 M
44.01 M
Cash Flow From Operations
(52.11 M)
169.12 M
(63.89 M)
(45.75 M)
(18.71 M)
32.4 M
(21.43 M)
(88.51 M)
(39.02 M)
(5.72 M)
Total Debt
10.19 M
1.01 B
112.03 M
134.2 M
38.99 M
209.1 M
34.89 M
192.22 M
30.61 M
69.29 M
Return On Equity
-14.97
0.0331
-0.34
-0.21
-0.22
0.0177
-7.75
-2.23
-0.79
-0.15
Z Score
-13.78
2.23
N/A
N/A
N/A
N/A
-2.62
N/A
N/A
N/A
Return On Asset
-0.35
0.0242
-0.0839
-0.0237
-0.12
0.0208
-0.29
-0.12
-0.31
-0.0275
Number Of Shares Shorted
65.91 K
5.76 M
3.59 M
1.37 M
1.11 M
614.53 K
68.02 K
4.88 M
1.95 M
1.09 M
Book Value Per Share
-2.08
17.02
1.67
13.76
3.95
26.73
-1.36
1.16
2.69
2.26
Current Liabilities
N/A
99.62 M
N/A
52.94 M
1.22 M
415.63 M
N/A
45.78 M
N/A
3.71 M
Total Asset
70.24 M
2.22 B
340.7 M
925.32 M
230.43 M
1.69 B
68.84 M
268.64 M
115.23 M
196.83 M
Debt To Equity
0.54
1.22
0.24
0.078
0.36
0.24
3.5
N/A
0.003
0.71
Short Ratio
0.77
10.29
4.13
3.89
2.47
1.9
3.98
9.66
5.33
2.75
Target Price
2.25
44.0
14.33
24.4
22.78
22.5
10.5
60.29
18.17
18.0
Shares Owned By Institutions
23.05
99.73
60.88
92.26
97.68
96.08
70.44
98.62
71.9
84.62
Market Capitalization
1.68 M
2.08 B
872.37 M
686.33 M
562.81 M
825.85 M
23.72 M
1.32 B
311.3 M
623.16 M
Price To Earnings To Growth
-0.02
4.83
N/A
0.33
-1.04
2.29
N/A
N/A
N/A
N/A
Price To Earning
N/A
51.79
N/A
338.0
N/A
51.23
N/A
-20.11
0.19
-47.07
Price To Sales
0.25
1.79
3.56
0.88
3.58
1.21
1.29
8.64
6.59
3.45
Net Income
(54.6 M)
40.41 M
(47.84 M)
(151.4 M)
(43.34 M)
(61.8 M)
(32.9 M)
(78.5 M)
(41.2 M)
(21.72 M)
Earnings Per Share
-8.12
0.53
-0.67
-3.14
-0.91
0.47
-2.18
-2.59
-2.69
-0.33
Shares Owned By Insiders
17.15
0.27
40.64
4.99
2.32
2.97
2.18
11.27
4.39
5.55
Revenue
81.98 M
1.2 B
216.39 M
746.64 M
138.89 M
673.3 M
49.19 M
165.15 M
39.3 M
159.01 M
Working Capital
35.56 M
149.16 M
164.57 M
255.22 M
187.94 M
252.4 M
8.08 M
117.75 M
104.23 M
57.57 M
Cash And Equivalents
29.34 M
225.98 M
73 M
59.54 M
114.41 M
106.5 M
16.49 M
65.35 M
109.98 M
58.03 M
Cash Per Share
4.35
4.34
0.95
2.98
3.34
2.26
1.21
2.68
5.34
1.37
Gross Profit
40.29 M
865.43 M
148.93 M
337.17 M
90.7 M
450 M
19.22 M
106.59 M
17.47 M
114.44 M
Day Typical Price
0.0337
42.64
10.26
17.96
13.35
18.08
2.41
45.86
13.01
14.11
Accumulation Distribution
0.11
0.0252
0.0479
0.0193
0.0325
0.0224
0.0369
0.0417
0.0441
0.0328
Market Facilitation Index
0.0039
1.09
0.5
0.35
0.44
0.41
0.09
1.95
0.59
0.47
Daily Balance Of Power
1.0
(0.78)
0.38
(0.37)
(0.43)
(1.15)
N/A
0.1487
(0.97)
(0.53)
Period Momentum Indicator
0.0039
(0.85)
0.19
(0.13)
(0.19)
(0.47)
N/A
0.29
(0.57)
(0.25)
Rate Of Daily Change
1.13
0.98
1.02
0.99
0.99
0.97
1.0
1.01
0.96
0.98
Day Median Price
0.0331
42.79
10.18
17.97
13.32
18.13
2.4
45.8
13.1
14.09
Price Action Indicator
0.0039
(0.86)
0.34
(0.07)
0.005
(0.40)
0.045
0.35
(0.55)
(0.05)
Relative Strength Index
27.1
46.04
67.95
62.58
42.55
48.73
46.04
61.57
69.58
52.59
Coefficient Of Variation
(433.53)
(9,695)
879.98
2037.82
(3,013)
(783.42)
797.41
1997.18
628.36
2779.43
Mean Deviation
8.82
1.23
3.61
1.66
2.77
1.72
3.96
3.27
3.75
2.36
Jensen Alpha
(3.55)
0.0175
0.4692
(0.02)
(0.30)
(0.54)
0.6321
0.0747
0.8922
0.0018
Total Risk Alpha
(5.18)
(0.23)
(0.08)
(0.17)
(0.62)
(0.73)
(0)
(0.35)
0.2004
(0.32)
Sortino Ratio
N/A
N/A
0.1579
0.0024
N/A
N/A
0.1325
0.031
0.202
0.0063
Downside Variance
N/A
N/A
14.21
3.74
N/A
N/A
18.29
16.61
18.13
15.35
Standard Deviation
14.56
1.65
6.12
2.13
3.88
2.86
5.32
4.52
6.03
3.47
Kurtosis
13.2
0.7279
19.52
0.7311
3.97
21.49
1.92
0.9073
9.24
3.9
Potential Upside
11.21
3.31
7.32
3.87
5.99
3.01
8.44
8.2
10.68
4.75
Treynor Ratio
(1.72)
0.0548
0.2857
0.0734
(0.08)
(0.21)
2.41
0.1376
1.48
0.0916
Maximum Drawdown
98.44
7.19
43.16
12.11
26.24
20.91
30.62
22.26
41.08
21.6
Variance
212.1
2.73
37.44
4.55
15.02
8.17
28.26
20.46
36.41
12.06
Market Risk Adjusted Performance
(1.71)
0.0648
0.2957
0.0834
(0.07)
(0.20)
2.42
0.1476
1.49
0.1016
Risk Adjusted Performance
(0.16)
(0)
0.0912
0.0422
(0.02)
(0.09)
0.0996
0.0447
0.1242
0.034
Skewness
(2.17)
0.4787
3.53
0.3078
(0.72)
(3.38)
0.7529
0.6281
2.14
(0.68)
Semi Deviation
N/A
N/A
3.34
1.85
N/A
N/A
3.84
3.81
3.38
3.77
Information Ratio
(0.24)
(0.07)
0.0973
0.0021
(0.06)
(0.16)
0.1066
0.0279
0.1426
0.0071
Value At Risk
(20.00)
(2.75)
(5.83)
(3.15)
(4.54)
(2.91)
(7.23)
(6.43)
(8.91)
(5.50)
Expected Short fall
N/A
N/A
(4.15)
(1.87)
N/A
N/A
(5.00)
(3.48)
(4.43)
(2.35)
Downside Deviation
N/A
N/A
3.77
1.94
N/A
N/A
4.28
4.08
4.26
3.92
Semi Variance
N/A
N/A
11.15
3.42
N/A
N/A
14.73
14.48
11.45
14.2

Surgalign Holdings Competition Performance Charts

Five steps to successful analysis of Surgalign Holdings Competition

Surgalign Holdings' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Surgalign Holdings in relation to its competition. Surgalign Holdings' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Surgalign Holdings in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Surgalign Holdings' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Surgalign Holdings, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Surgalign Holdings position

In addition to having Surgalign Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment
Electronic Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Surgalign Stock

If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY